Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), David R. Newell(Newcastle University), Ian R. Hardcastle(Cancer Research UK), Allyson J. Campbell(Newcastle University), Lan-Zeng Wang(Newcastle University), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Yuzhu Cheng(Soochow University), Mara Binda, María Ángeles Curto(Institute of Chemistry of Molecular Recognition), Roger J. Griffin(Newcastle University), Nicola J. Curtin(Newcastle University), Andrew Henderson(Newcastle University), Bernard T. Golding(Newcastle University)
Cited by 72
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274